Peng et al.[11] also reported that CDCA2 recruits PP1γ to chromatin to antagonize activation of ATM-dependent signal transduction and that CDCA2-dependent DDR regulation is strengthened by CDCA2 overexpression during cancer progression, resulting in reduced DDR sensitivity. The gene discussed is CDCA2; the disease is cancer.